COLLIN A. HOVINGA, Pharm.D.

Assistant Professor

Department of Pharmacy

Department of Pediatrics

The University of Tennessee Health Science Center

Address

The University of Tennessee Health Science Center

26 S Dunlap St. 501E

Memphis, TN 38163

Tel: (901) 448-1689; Fax: (901) 448-6064;

Education

Pharm.D. Institution: Creighton University School of Pharmacy and Allied Health Professions, Omaha, NE

Postdoctoral: NIH Pediatric Pharmacology Research Unit, University of Tennessee, Memphis, TN

Recent Publications

• Wheless JW, Manjunath R, Phelps SJ, Asato MR, Sheth RD, Hovinga CA, Pina-Garza JE, Haskins LS, Zingaro WM. Seizure emergency plans: Patient results from a cross-sectional epilepsy survey. Epilepsy Behav. 2008 Jul 9; [Epub ahead of print] PMID: 18619905
• Whelan HT, Cook JD, Amlie-Lefond CM, Hovinga CA, Chan AK, Ichord RN, Deveber GA, Thall PF. Practical model-based dose finding in early-phase clinical trials: optimizing tissue plasminogen activator dose for treatment of ischemic stroke in children. Stroke. 2008 Sep;39(9):2627-36. Epub 2008 Jul 10. PMID: 18617665
• Hovinga CA, Asato MR, Manjunath R, Wheless JW, Phelps SJ, Sheth RD, Pina-Garza JE, Zingaro WM, Haskins LS. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008 Aug;13(2):316-22. Epub 2008 May 9. PMID: 18472303
• Hovinga CA. Valrocemide (Teva/Acorda). Curr Opin Investig Drugs. 2004 Jan;5(1):101-6. Review. PMID: 14983982
• Lardizabal DV, Lüders HO, Hovinga CA, Bourgeois BF. Severe intoxication after phenytoin infusion: a preventable pharmacogenetic adverse reaction. Neurology. 2004 Jan 13;62(1):161; author reply 161. No abstract available. PMID: 14727316
• Srikijvilaikul T, Najm IM, Hovinga CA, Prayson RA, Gonzalez-Martinez J, Bingaman WE. Seizure outcome after temporal lobectomy in temporal lobe cortical dysplasia. Epilepsia. 2003 Nov;44(11):1420-4. PMID: 14636350

view complete list of references (pubmed link)